Skip to main content
Erschienen in: The European Journal of Health Economics 1/2014

01.05.2014 | Original Paper

Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective

verfasst von: Márta Péntek, Bernadette Rojkovich, László Czirják, Pál Géher, Péter Keszthelyi, Attila Kovács, László Kovács, Zita Szabó, Zoltán Szekanecz, László Tamási, Ágnes Edit Tóth, Ilona Ujfalussy, Noémi Vártokné Hevér, Bálint Strbák, Petra Baji, Valentin Brodszky, László Gulácsi

Erschienen in: The European Journal of Health Economics | Sonderheft 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Some health problems are considered by many individuals as a ‘normal’ part of ageing. Our aim was to investigate whether patients with rheumatoid arthritis (RA) consider different types and levels of health losses as acceptable beyond a certain age. A multicenter cross-sectional survey was performed involving RA patients at the initiation of the first biological therapy. The EQ-5D and the Health Assessment Questionnaire Disability Index (HAQ-DI) questionnaires were used to describe domain-specific health states. Patients were asked to indicate for each domain from what age and onward (between ages 30 and 80 years in 10 year intervals) they considered moderate and severe problems acceptable or alternatively never acceptable. Seventy-seven RA patients (females 86 %, mean age 50.3, disease duration 9.1 years) completed the questionnaire. Disease activity (DAS28), EQ-5D and HAQ-DI scores were mean 6.00 (SD 0.85), 0.35 (SD 0.36), 1.48 (SD 0.66), respectively. The majority of the patients considered age 70 and beyond as acceptable to have some health problems (EQ-5D: self-care 42 %, pain/discomfort 34 %, mobility 33 %, usual activities 33 %, anxiety/depression 27 %), whilst at ages 30 and 40 as not acceptable. Severe health problems were mostly (57–69 %) considered never acceptable, except the ‘Usual activities’ domain (acceptable from age 80 by 50.6 %). The great majority of the patients (77–96 %) were younger than what they indicated as the acceptability age limit. Similar results were found for the HAQ-DI. This small experimental study suggests that RA patients consider some health problems acceptable. This acceptability is age related and varies by health areas. Further larger studies are needed to explore explanatory variables and to compare with other diseases. Owing to the impact acceptability might have on RA patients’ self-evaluation of current health state and decision-making, the topic deserves methodological improvement and further investigation.
Literatur
1.
Zurück zum Zitat WHO: Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948 (1948) WHO: Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948 (1948)
3.
Zurück zum Zitat Hung, L.-W., Kempen, G.I.J.M., De Vries, N.K.: Cross-cultural comparison between academic and lay views of healthy ageing: a literature review. Ageing Soc. 30(8), 1373–1391 (2010)CrossRef Hung, L.-W., Kempen, G.I.J.M., De Vries, N.K.: Cross-cultural comparison between academic and lay views of healthy ageing: a literature review. Ageing Soc. 30(8), 1373–1391 (2010)CrossRef
4.
Zurück zum Zitat Bleichrodt, H., Herrero, C., Pinto, J.L.: A proposal to solve the comparability problem in cost–utility analysis. J. Health Econ. 21(3), 397–403 (2002)PubMedCrossRef Bleichrodt, H., Herrero, C., Pinto, J.L.: A proposal to solve the comparability problem in cost–utility analysis. J. Health Econ. 21(3), 397–403 (2002)PubMedCrossRef
5.
Zurück zum Zitat Brouwer, W.B., van Exel, N.J., Stolk, E.A.: Acceptability of less than perfect health states. Soc. Sci. Med. 60(2), 237–246 (2005)PubMedCrossRef Brouwer, W.B., van Exel, N.J., Stolk, E.A.: Acceptability of less than perfect health states. Soc. Sci. Med. 60(2), 237–246 (2005)PubMedCrossRef
6.
Zurück zum Zitat EuroQol, G.: EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3), 199–208 (1990)CrossRef EuroQol, G.: EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3), 199–208 (1990)CrossRef
7.
Zurück zum Zitat Smolen, J.S., Landewe, R., Breedveld, F.C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., Ramiro, S., Winthrop, K., de Wit, M., Aletaha, D., Betteridge, N., Bijlsma, J.W., Boers, M., Buttgereit, F., Combe, B., Cutolo, M., Damjanov, N., Hazes, J.M., Kouloumas, M., Kvien, T.K., Mariette, X., Pavelka, K., van Riel, P.L., Rubbert-Roth, A., Scholte-Voshaar, M., Scott, D.L., Sokka-Isler, T., Wong, J.B., van der Heijde, D.: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 73(3), 492–509 (2014)PubMedCentralPubMedCrossRef Smolen, J.S., Landewe, R., Breedveld, F.C., Buch, M., Burmester, G., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J., Ramiro, S., Winthrop, K., de Wit, M., Aletaha, D., Betteridge, N., Bijlsma, J.W., Boers, M., Buttgereit, F., Combe, B., Cutolo, M., Damjanov, N., Hazes, J.M., Kouloumas, M., Kvien, T.K., Mariette, X., Pavelka, K., van Riel, P.L., Rubbert-Roth, A., Scholte-Voshaar, M., Scott, D.L., Sokka-Isler, T., Wong, J.B., van der Heijde, D.: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 73(3), 492–509 (2014)PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Poulos, C., Hauber, A.B., Gonzalez, J.M., Turpcu, A.: Patients’ willingness to trade off between the duration and frequency of rheumatoid arthritis treatments. Arthritis Care Res (Hoboken) (2013). doi:10.1002/acr.22265 Poulos, C., Hauber, A.B., Gonzalez, J.M., Turpcu, A.: Patients’ willingness to trade off between the duration and frequency of rheumatoid arthritis treatments. Arthritis Care Res (Hoboken) (2013). doi:10.​1002/​acr.​22265
9.
Zurück zum Zitat Augustovski, F., Beratarrechea, A., Irazola, V., Rubinstein, F., Tesolin, P., Gonzalez, J., Lencina, V., Scolnik, M., Waimann, C., Navarta, D., Citera, G., Soriano, E.R.: Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment. Value Health 16(2), 385–393 (2013)PubMedCrossRef Augustovski, F., Beratarrechea, A., Irazola, V., Rubinstein, F., Tesolin, P., Gonzalez, J., Lencina, V., Scolnik, M., Waimann, C., Navarta, D., Citera, G., Soriano, E.R.: Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment. Value Health 16(2), 385–393 (2013)PubMedCrossRef
10.
Zurück zum Zitat Meesters, J., de Boer, I., van den Berg, M., Fiocco, M., Vliet Vlieland, T.: Unmet information needs about the delivery of rheumatology health care services: a survey among patients with rheumatoid arthritis. Patient Educ. Couns. 85(2), 299–303 (2011)PubMedCrossRef Meesters, J., de Boer, I., van den Berg, M., Fiocco, M., Vliet Vlieland, T.: Unmet information needs about the delivery of rheumatology health care services: a survey among patients with rheumatoid arthritis. Patient Educ. Couns. 85(2), 299–303 (2011)PubMedCrossRef
11.
Zurück zum Zitat Harrison, M.J., Davies, L.M., Bansback, N.J., Ingram, M., Anis, A.H., Symmons, D.P.: The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J. Rheumatol. 35(4), 592–602 (2008)PubMed Harrison, M.J., Davies, L.M., Bansback, N.J., Ingram, M., Anis, A.H., Symmons, D.P.: The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J. Rheumatol. 35(4), 592–602 (2008)PubMed
12.
Zurück zum Zitat Szende, A., Nemeth, R.: Health-related quality of life of the Hungarian population. Orv. Hetil. 144(34), 1667–1674 (2003)PubMed Szende, A., Nemeth, R.: Health-related quality of life of the Hungarian population. Orv. Hetil. 144(34), 1667–1674 (2003)PubMed
13.
Zurück zum Zitat Maska, L., Anderson, J., Michaud, K.: Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL). Arthritis Care Res (Hoboken) 63(Suppl 11), S4–S13 (2011)CrossRef Maska, L., Anderson, J., Michaud, K.: Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ), and Rheumatoid Arthritis Quality of Life (RAQoL). Arthritis Care Res (Hoboken) 63(Suppl 11), S4–S13 (2011)CrossRef
14.
Zurück zum Zitat Péntek, M., Rojkovich, B., Czirják, L., Géher, P., Keszthelyi, P., Kovács, A., Kovács, L., Náfrádi, L., Szanyó, F., Szekanecz, Z., Tamási, L., Tóth, E., Ujfalussy, I., Varjú, T., Gulácsi, L.: Biológikumok Alkalmazása Rheumatoid Arthritisben – Terápiafelmérés (BARAT vizsgálat): biológiai terápiát kezdő betegek klinikai jellemzői és egészségügyi szolgáltatások igénybevételének jellemzői. Immunol. Szle. 3(4), 36–48 (2011) Péntek, M., Rojkovich, B., Czirják, L., Géher, P., Keszthelyi, P., Kovács, A., Kovács, L., Náfrádi, L., Szanyó, F., Szekanecz, Z., Tamási, L., Tóth, E., Ujfalussy, I., Varjú, T., Gulácsi, L.: Biológikumok Alkalmazása Rheumatoid Arthritisben – Terápiafelmérés (BARAT vizsgálat): biológiai terápiát kezdő betegek klinikai jellemzői és egészségügyi szolgáltatások igénybevételének jellemzői. Immunol. Szle. 3(4), 36–48 (2011)
15.
Zurück zum Zitat Péntek, M., Gulácsi, L., Rojkovich, B., Brodszky, V., van Exel, J., Brouwer, W.B.F.: Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists. Eur. J. Health Econ. (2014). doi:10.1007/s10198-014-0597-1 Péntek, M., Gulácsi, L., Rojkovich, B., Brodszky, V., van Exel, J., Brouwer, W.B.F.: Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists. Eur. J. Health Econ. (2014). doi:10.​1007/​s10198-014-0597-1
16.
Zurück zum Zitat Anderson, J.K., Zimmerman, L., Caplan, L., Michaud, K.: Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res (Hoboken) 63(Suppl 11), S14–S36 (2011)CrossRef Anderson, J.K., Zimmerman, L., Caplan, L., Michaud, K.: Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res (Hoboken) 63(Suppl 11), S14–S36 (2011)CrossRef
18.
Zurück zum Zitat Buitinga, L., Braakman-Jansen, L.M., Taal, E., van de Laar, M.A.: Worst-case future scenarios of patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford) 51(11), 2027–2033 (2012)CrossRef Buitinga, L., Braakman-Jansen, L.M., Taal, E., van de Laar, M.A.: Worst-case future scenarios of patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford) 51(11), 2027–2033 (2012)CrossRef
19.
Zurück zum Zitat Buitinga, L., Braakman-Jansen, L.M., Taal, E., van de Laar, M.A.: Future expectations and worst-case future scenarios of patients with rheumatoid arthritis: a focus group study. Musculoskeletal Care 10(4), 240–247 (2012)PubMedCrossRef Buitinga, L., Braakman-Jansen, L.M., Taal, E., van de Laar, M.A.: Future expectations and worst-case future scenarios of patients with rheumatoid arthritis: a focus group study. Musculoskeletal Care 10(4), 240–247 (2012)PubMedCrossRef
20.
Zurück zum Zitat Sanderson, T., Hewlett, S., Richards, P., Morris, M., Calnan, M.: Utilizing qualitative data from nominal groups: exploring the influences on treatment outcome prioritization with rheumatoid arthritis patients. J. Health Psychol. 17(1), 132–142 (2012)PubMedCrossRef Sanderson, T., Hewlett, S., Richards, P., Morris, M., Calnan, M.: Utilizing qualitative data from nominal groups: exploring the influences on treatment outcome prioritization with rheumatoid arthritis patients. J. Health Psychol. 17(1), 132–142 (2012)PubMedCrossRef
21.
Zurück zum Zitat Boncz, I., Sebestyen, A.: Economy and mortality in Eastern and Western Europe between 1945 and 1990: the largest medical trial of history. Int. J. Epidemiol. 35(3), 796–797; author reply 797–799 (2006) Boncz, I., Sebestyen, A.: Economy and mortality in Eastern and Western Europe between 1945 and 1990: the largest medical trial of history. Int. J. Epidemiol. 35(3), 796–797; author reply 797–799 (2006)
22.
Zurück zum Zitat Boncz, I., Sebestyen, A.: Financial deficits in the health services of the UK and Hungary. Lancet 368(9539), 917–918 (2006)PubMedCrossRef Boncz, I., Sebestyen, A.: Financial deficits in the health services of the UK and Hungary. Lancet 368(9539), 917–918 (2006)PubMedCrossRef
23.
Zurück zum Zitat Kovacs, A., Dobrossy, L., Budai, A., Boncz, I., Cornides, A.: Cervical screening in Hungary: why does the “English model” work but the “Hungarian model” does not? Eur. J. Gynaecol. Oncol. 29(1), 5–9 (2008)PubMed Kovacs, A., Dobrossy, L., Budai, A., Boncz, I., Cornides, A.: Cervical screening in Hungary: why does the “English model” work but the “Hungarian model” does not? Eur. J. Gynaecol. Oncol. 29(1), 5–9 (2008)PubMed
24.
Zurück zum Zitat Krishnan, E., Sokka, T., Hakkinen, A., Hubert, H., Hannonen, P.: Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population. Arthritis Rheum. 50(3), 953–960 (2004)PubMedCrossRef Krishnan, E., Sokka, T., Hakkinen, A., Hubert, H., Hannonen, P.: Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population. Arthritis Rheum. 50(3), 953–960 (2004)PubMedCrossRef
25.
Zurück zum Zitat Sokka, T., Makinen, H., Hannonen, P., Pincus, T.: Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology (Oxford) 46(6), 1020–1023 (2007)CrossRef Sokka, T., Makinen, H., Hannonen, P., Pincus, T.: Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology (Oxford) 46(6), 1020–1023 (2007)CrossRef
26.
Zurück zum Zitat Sallai, J.R., Hunka, A., Hejj, G., Ratko, I., Ortutay, J., Markus, I., Ormos, G., Ujfalussy, A., Szekeres, L., Insperger, A., Varju, T., Balint, G.: Survey of quality of life of rheumatoid arthritis patients admitted to rehabilitation centres in Hungary. Orv. Hetil. 154(35), 1381–1388 (2013)PubMedCrossRef Sallai, J.R., Hunka, A., Hejj, G., Ratko, I., Ortutay, J., Markus, I., Ormos, G., Ujfalussy, A., Szekeres, L., Insperger, A., Varju, T., Balint, G.: Survey of quality of life of rheumatoid arthritis patients admitted to rehabilitation centres in Hungary. Orv. Hetil. 154(35), 1381–1388 (2013)PubMedCrossRef
27.
Zurück zum Zitat Cutolo, M., Kitas, G.D., van Riel, P.L.: Burden of disease in treated rheumatoid arthritis patients: going beyond the joint. Semin. Arthritis Rheum. 43(4), 479–488 (2014)PubMedCrossRef Cutolo, M., Kitas, G.D., van Riel, P.L.: Burden of disease in treated rheumatoid arthritis patients: going beyond the joint. Semin. Arthritis Rheum. 43(4), 479–488 (2014)PubMedCrossRef
28.
Zurück zum Zitat Marra, C.A., Woolcott, J.C., Kopec, J.A., Shojania, K., Offer, R., Brazier, J.E., Esdaile, J.M., Anis, A.H.: A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc. Sci. Med. 60(7), 1571–1582 (2005)PubMedCrossRef Marra, C.A., Woolcott, J.C., Kopec, J.A., Shojania, K., Offer, R., Brazier, J.E., Esdaile, J.M., Anis, A.H.: A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc. Sci. Med. 60(7), 1571–1582 (2005)PubMedCrossRef
29.
Zurück zum Zitat Felson, D.T., Anderson, J.J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L.M., Lightfoot Jr, R., Paulus, H., Strand, V., et al.: American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 38(6), 727–735 (1995)PubMedCrossRef Felson, D.T., Anderson, J.J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L.M., Lightfoot Jr, R., Paulus, H., Strand, V., et al.: American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 38(6), 727–735 (1995)PubMedCrossRef
30.
Zurück zum Zitat Pease, C., Pope, J.E., Truong, D., Bombardier, C., Widdifield, J., Thorne, J.C., Paul Haraoui, B., Psaradellis, E., Sampalis, J., Bonner, A.: Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. Semin. Arthritis Rheum. 41(1), 81–89 (2011)PubMedCrossRef Pease, C., Pope, J.E., Truong, D., Bombardier, C., Widdifield, J., Thorne, J.C., Paul Haraoui, B., Psaradellis, E., Sampalis, J., Bonner, A.: Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy. Semin. Arthritis Rheum. 41(1), 81–89 (2011)PubMedCrossRef
31.
Zurück zum Zitat Kobelt, G.: Thoughts on health economics in rheumatoid arthritis. Ann. Rheum. Dis. 66(Suppl 3), iii35–39 (2007) Kobelt, G.: Thoughts on health economics in rheumatoid arthritis. Ann. Rheum. Dis. 66(Suppl 3), iii35–39 (2007)
Metadaten
Titel
Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective
verfasst von
Márta Péntek
Bernadette Rojkovich
László Czirják
Pál Géher
Péter Keszthelyi
Attila Kovács
László Kovács
Zita Szabó
Zoltán Szekanecz
László Tamási
Ágnes Edit Tóth
Ilona Ujfalussy
Noémi Vártokné Hevér
Bálint Strbák
Petra Baji
Valentin Brodszky
László Gulácsi
Publikationsdatum
01.05.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
The European Journal of Health Economics / Ausgabe Sonderheft 1/2014
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-014-0596-2

Weitere Artikel der Sonderheft 1/2014

The European Journal of Health Economics 1/2014 Zur Ausgabe